Business Standard

Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs

Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray

Lupin
Premium

Sohini Das Mumbai
After injectables and oral solid drugs, pharmaceutical companies are focusing on coming up with re-purposed inhalation products for Covid-19.
 
While Lupin is working on a remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.
 
Remdesivir, an antiviral drug developed by American drug major Gilead for Ebola, was repurposed for Covid-19. The drug was in such demand during the first and second waves of the pandemic that massive shortages and spiralling black-market prices were reported.
 
Mumbai-based drug major Lupin has now

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 29 2021 | 5:04 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com